Stay updated on Nivolumab in Resectable Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable Osteosarcoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:32:37.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.
    Difference
    1%
    Check dated 2025-02-10T15:22:45.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:40:22.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-01-27T04:45:46.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.4%
    Check dated 2025-01-20T01:59:41.000Z thumbnail image
  9. Check
    64 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.3%
    Check dated 2025-01-12T22:41:10.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.